|
인쇄하기
취소
|
Overall pharmaceutical industry stocks declined.
Published: 2006-05-26 06:57:00
Updated: 2006-05-26 06:57:00
In the Korea Stock Exchange Market overall pharmaceutical industry stocks lost its attractiveness mainly due to the recent bio equivalency test scandals, and therefore the total industry equity remarkably devalued.
On May 18 the stock prices of the total 75 Kosdaq drug companies showed only 4 companies up (Shinil, Keunwha, Daehan Newpharm and Inbionet), 6 companies flat and 65 companies down...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.